MedTrace Logo

Postmarket Study of JUVÉDERM VOLBELLA™ With Lidocaine in the Lips

NCT01629134 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 62

Last updated 2014-10-13

Study results available
· View outcomes & findings →

Summary

A prospective, multicenter postmarket study of the use of JUVÉDERM VOLBELLA™ with Lidocaine in the lips.

Conditions

  • Lip Augmentation

Interventions

DEVICE

Crosslinked hyaluronic acid gel

All treatments are carried out according to the physician's experience and the Directions for Use

Sponsors & Collaborators

  • Allergan Medical

    lead INDUSTRY

Principal Investigators

  • Medical Monitor · Allergan Medical

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01629134 on ClinicalTrials.gov